Publicaciones (135) Publicaciones de ENRIQUE CASADO SAENZ

2023

  1. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy

    Frontiers in Immunology, Vol. 14

  2. Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer

    BMC Cancer, Vol. 23, Núm. 1

  3. Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review

    Current Oncology, Vol. 30, Núm. 10, pp. 9335-9345

  4. M-Health in lung cancer: A literature review

    SAGE Open Medicine, Vol. 11

  5. The mHealth ALIBIRD Platform: Supporting Cancer Patient Treatment and Follow-up

    Proceedings - IEEE Symposium on Computer-Based Medical Systems

2022

  1. Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic

    Frontiers in Oncology, Vol. 12

2021

  1. Article a multicenter analysis of the outcome of cancer patients with neutropenia and covid-19 optionally treated with granulocyte-colony stimulating factor (G-csf): A comparative analysis

    Cancers, Vol. 13, Núm. 16

  2. Immune checkpoint inhibitors in endometrial cancer

    Critical Reviews in Oncology/Hematology, Vol. 161

  3. Metabolic health together with a lipid genetic risk score predicts survival of small cell lung cancer patients

    Cancers, Vol. 13, Núm. 5, pp. 1-8

  4. Nutrigenómica y cáncer en los tiempos del COVID-19

    Revista de nutrición práctica, Año 25, pp. 58-59

  5. Ras mutational status in advanced colorectal adenocarcinoma treated with anti-angiogenics: Preliminary experience with liquid biopsy

    In Vivo, Vol. 35, Núm. 5, pp. 2841-2844

2020

  1. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?

    Lung Cancer

  2. Adjuvant chemotherapy in endometrial cancer

    Cancer Chemotherapy and Pharmacology, Vol. 85, Núm. 3, pp. 477-486

  3. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

    Cancer Biology and Medicine, Vol. 17, Núm. 2, pp. 444-457

  4. Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer

    Molecular Oncology, Vol. 14, Núm. 12, pp. 3135-3152

2019

  1. Erratum to “Lipid metabolism and lung cancer” [Crit. Rev. Oncol. Hematol. 112, April (2017), 31–40](S1040842817300513)(10.1016/j.critrevonc.2017.02.001)

    Critical Reviews in Oncology/Hematology

  2. Tolerability and safety of a nutritional supplement with potential as adjuvant in colorectal cancer therapy: A randomized trial in healthy volunteers

    Nutrients, Vol. 11, Núm. 9

2018

  1. Antinuclear antibodies and cancer: A literature review

    Critical Reviews in Oncology/Hematology, Vol. 127, pp. 42-49

  2. Estimated Time of Arrival Sensitivity to Aircraft Intent Uncertainty

    15th IFAC Symposium on Control in Transportation Systems CTS 2018

  3. Evaluation of the applicability of a modern aircraft performance model to trajectory optimization

    AIAA/IEEE Digital Avionics Systems Conference - Proceedings